Mirae Asset Venture Investment participated in Cellweaverse's KRW 6 billion Pre-Series A round for cell culture-based pharmaceutical and bio materials
Cellweaverse was founded to sustainably provide essential animal-derived materials for human use
Cellweaverse was founded to sustainably provide essential animal-derived materials for human use. Our innovative cell line development and cultivation technologies enable the production of valuable animal-derived materials without the need for animal farming or harvesting. This approach addresses concerns related to material safety, supply chain stability, environmental impact, and animal welfare.